Pharma Industry News
A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
Zealand Pharma to participate in the Morgan Stanley 24th Annual Global Healthcare Conference
Press release – No. 15 / 2026 Zealand Pharma to participate in the Morgan Stanley 24 Annual Global Healthcare Conference Copenhagen, Denmark, September 9, 2026 - Zealand Pharma A/S (Nasdaq: ZEAL) (CVR-no. 20045078), a biotechnology company…
Kubota Pharma 1H Loss Y649.00M Vs Loss Y450.00M
Kubota Pharmaceutical Holdings Co. Ltd. (4596.TO) Japan Half-Year Ended June 30 GROUP 2026 2025 Revenue Y8.00 mln Y13.00 mln Operating Profit (Y650.00 mln) (Y450.00 mln) Pretax Profit (Y649.00 mln) (Y450.00 mln) Net Profit (Y649.00 mln) (Y450.00…
Innocan Pharma Announces Private Placement of Units
HERZLIYA, Israel and CALGARY, Alberta, Sept. 9, 2026 /CNW/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTC: INNPF) (the 'Company' or 'Innocan') is pleased to announce that it intends to complete a private placement of up to 535,000 units…
Urogen Pharma: Upside After Bladder Cancer Launch (NASDAQ:URGN)
UroGen Pharma Ltd. has transitioned into a commercial-stage biopharma, driven by strong adoption of Zusduri for recurrent non-muscle-invasive bladder cancer. Zusduri achieved an 80% complete response rate in the ENVISION trial, with a 64.5% chance…
Zealand Pharma: A Play On Medicine Discovery, But Too Expensive Right Now (OTCMKTS:ZLDPF)
Zealand Pharma (ZEAL) offers a differentiated obesity drug pipeline, notably Petrelintide, with strong tolerability and strategic Roche collaboration. ZEAL's Roche deal secures $1.65B upfront plus substantial milestones, 50% profit share in US/EU…
GLP-1 boom pushes pharma companies deeper into wellness, nutraceuticals
The rapid growth of GLP-1 drugs for weight loss is prompting pharmaceutical companies to look beyond the medicines themselves, with wellness and nutraceuticals emerging as adjacent opportunities in the fast-growing weight-management market.
John Smither Sells 1,600 Shares of NewAmsterdam Pharma (NASDAQ:NAMS) Stock
NewAmsterdam Pharma Company N.V. (NASDAQ:NAMS - Get Free Report) Director John Smither sold 1,600 shares of the firm's stock in a transaction dated Friday, September 4th. The shares were sold at an average price of $25.32, for a total transaction…
Jim Cramer's top 10 things to watch in the stock market Wednesday
My top 10 things to watch Wednesday, Sept. 9 1. Back to $100 a barrel we go on Brent crude. Stock futures, predictably, are lower this morning. It will be very hard for stocks to rally facing $100 oil this time because of the huge drawdowns of the…
BridgeBio Pharma, Inc. $BBIO Shares Bought by Squarepoint Ops LLC
Squarepoint Ops LLC boosted its holdings in BridgeBio Pharma, Inc. (NASDAQ:BBIO - Free Report) by 114.2% during the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional…
C.H. Robinson: The $604 Million Verdict Looks Bigger Than The Economic Risk (NASDAQ:CHRW)
C.H. Robinson Worldwide faces headline risk from a $604 million verdict, but insurance and fault allocation significantly limit direct financial exposure. Montgomery v. Caribe Transport II increases legal risk for brokers, but the true impact will…
2 Dividend Stocks Built to Hold Up When Markets Don't
The S&P 500 has advanced for the past three calendar years and continues to march higher in 2026, even reaching record levels. But this isn't without interruption, particularly in recent months. Investors have worried about the ongoing turmoil in…
Halozyme Therapeutics, Inc. (HALO) Presents at Wells Fargo 21st Annual Healthcare Conference Transcript
Halozyme Therapeutics, Inc. (HALO) Wells Fargo 21st Annual Healthcare Conference September 9, 2026 3:45 PM EDT Helen Torley - President, CEO & Director Mohit Bansal - Wells Fargo Securities, LLC, Research Division Wells Fargo Securities, LLC…
Uber initiated, Thermo Fisher upgraded: Wall Street's top analyst calls
The most talked about and market moving research calls around Wall Street are now in one place. Here are today's research calls that investors need to know, as compiled by The Fly. UBS upgraded Thermo Fisher (TMO) to Buy from Neutral with a price…
Regeneron Pharmaceuticals, Inc. (REGN) Presents at Wells Fargo 21st Annual Healthcare Conference Transcript
Regeneron Pharmaceuticals, Inc. (REGN) Wells Fargo 21st Annual Healthcare Conference September 9, 2026 8:45 AM EDT Ryan Crowe - Senior Vice President of Investor Relations & Strategic Analysis Marion McCourt - Executive Vice President of Commercial…
Trump pal Peter Navarro rips Fox for firing Maria Bartiromo
Peter Navarro, a senior counselor to the president, has attacked Fox News following the firing of Maria Bartiromo, claiming the media corporation “has not treated Donald Trump very well.” The Trump official made a guest appearance on…
Receive a Daily briefing on Pharma Industry News
Get Started